Assessment of cardiovascular disease risk by plasma renin activity changes in patients with primary aldosteronism on mineralocorticoid receptor antagonist treatment-MedSci.cn - williamhill asia

Assessment of cardiovascular disease risk by plasma renin activity changes in patients with primary aldosteronism on mineralocorticoid receptor antagonist treatment

Morimoto, S; Ichihara, A

Morimoto, S (通讯作者)，Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan.

HYPERTENSION RESEARCH, 2022; 45 (9): 1517

科室
- - 订阅+
  - 更多科室
工具
服务